Laura Massella

3.6k total citations · 1 hit paper
42 papers, 1.8k citations indexed

About

Laura Massella is a scholar working on Nephrology, Genetics and Immunology and Allergy. According to data from OpenAlex, Laura Massella has authored 42 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Nephrology, 16 papers in Genetics and 14 papers in Immunology and Allergy. Recurrent topics in Laura Massella's work include Renal Diseases and Glomerulopathies (21 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers) and Cell Adhesion Molecules Research (14 papers). Laura Massella is often cited by papers focused on Renal Diseases and Glomerulopathies (21 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (15 papers) and Cell Adhesion Molecules Research (14 papers). Laura Massella collaborates with scholars based in Italy, United States and Germany. Laura Massella's co-authors include Francesco Emma, Marina Vivarelli, Barbara Ruggiero, Alessandra Renieri, Andrea Onetti Muda, Gianfranco Rizzoni, Gian Marco Ghiggeri, Francesco Scolari, Luisa Murer and Laurence Heidet and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and Human Molecular Genetics.

In The Last Decade

Laura Massella

40 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Minimal Change Disease

2016 322 citations Marina Vivarelli, Laura Massella et al. profile →

Peers

Countries citing papers authored by Laura Massella

Since Specialization

Citations

This map shows the geographic impact of Laura Massella's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Massella with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Massella more than expected).

Fields of papers citing papers by Laura Massella

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Massella. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Massella. The network helps show where Laura Massella may publish in the future.

Co-authorship network of co-authors of Laura Massella

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Massella. A scholar is included among the top collaborators of Laura Massella based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Massella. Laura Massella is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	NUP85 as a Neurodevelopmental Gene: From Podocyte to Neuron 2023 ·Genes ·(unknown), Giuseppe Donato Mangano, (unknown), Francesca Granata, Antonella Riva, Laura Massella, Isabella Guzzo, Giovanni Farello, (unknown), (unknown), (unknown), (unknown), (unknown), Saverio La Bella, Pasquale Striano, Stéphanie Efthymiou, Henry Houlden, Rosaria Nardello, Roberto Chimenz	2
2	Autosomal dominant and autosomal recessive polycystic kidney disease: hypertension and secondary cardiovascular effect in children 2023 ·Frontiers in Molecular Biosciences ·(unknown), Marcello Chinali, Francesco Emma, Laura Massella	2
3	Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice 2022 ·Pediatric Nephrology ·(unknown), Antonio Gatto, (unknown), Marina Vivarelli, Francesco Emma, Laura Massella	0
4	Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement 2022 ·The Italian Journal of Pediatrics/Italian journal of pediatrics ·Marcello Lanari, Elisabetta Venturini, Luca Pierantoni, (unknown), Guido Castelli Gattinara, Susanna Esposito, Silvia Favilli, Emilio Franzonı, (unknown), Paolo Lionetti, Claudio Maffeis, Gian Luigi Marseglia, Laura Massella, Fabio Midulla, (unknown), Marco Zecca, Alberto Villani, Annamaria Staiano, Luisa Galli, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	6
5	Prolonged Impairment of Immunological Memory After Anti-CD20 Treatment in Pediatric Idiopathic Nephrotic Syndrome 2019 ·Frontiers in Immunology ·Manuela Colucci, Rita Carsetti, Jessica Serafinelli, Salvatore Rocca, Laura Massella, Antonio Gargiulo, Anna Lo Russo, Claudia Capponi, Nicola Cotugno, Ottavia Porzio, Andrea Onetti Muda, Paolo Palma, Francesco Emma, Marina Vivarelli	44
6	Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group 2018 ·Kidney International ·Clifford E. Kashtan, Jie Ding, Guido Garosi, Laurence Heidet, Laura Massella, Koichi Nakanishi, Kandai Nozu, Alessandra Renieri, Michelle N. Rheault, Fang Wang, Oliver Groß	182
7	Rituximab in Steroid-Dependent or Frequently Relapsing Idiopathic Nephrotic Syndrome 2014 ·Journal of the American Society of Nephrology ·Piero Ruggenenti, Barbara Ruggiero, Paolo Cravedi, Marina Vivarelli, Laura Massella, Maddalena Marasà, Antonietta Chianca, Nadia Rubis, Bogdan Ene‐Iordache, Michael Rudnicki, Rosa Maria Pollastro, Giovambattista Capasso, Antonio Pisani, Marco Pennesi, Francesco Emma, Giuseppe Remuzzi	182
8	Bone marrow transplantation in Schimke immuno‐osseous dysplasia 2013 ·American Journal of Medical Genetics Part A ·Alireza Baradaran‐Heravi, J. Lange, Yumi Asakura, Pierre Cochat, Laura Massella, Cornelius F. Boerkoel	11
9	The levamisole study in steroid sensitive idiopathic nephrotic syndrome (SSINS): inclusion completed 2012 ·Ghent University Academic Bibliography (Ghent University) ·Mariken Gruppen, Antonia H. Bouts, Patrick Niaudet, Thierry Schurmans, Noël Knops, (unknown), Elena Levtchenko, Elisabeth A. M. Cornelissen, Ann Raes, Johan Vande Walle, (unknown), Aleksandra Żurowska, Francesco Emma, Laura Massella, Arvind Bagga, Ashima Gulati, Jean‐Claude Davin	3
10	Rituximab in Children with Resistant Idiopathic Nephrotic Syndrome 2012 ·Journal of the American Society of Nephrology ·Alberto Magnasco, Pietro Ravani, Alberto Edefonti, Luisa Murer, Luciana Ghio, Mirco Belingheri, Elisa Benetti, Corrado Murtas, Giovanni Messina, Laura Massella, (unknown), Michela Montagna, Mario Regazzi, Francesco Scolari, Gian Marco Ghiggeri	122
11	Cyclosporine A treatment in patients with Alport syndrome: a single-center experience 2010 ·Pediatric Nephrology ·Laura Massella, Andrea Onetti Muda, (unknown), (unknown), (unknown), Francesco Emma	20
12	Time for Initial Response to Steroids Is a Major Prognostic Factor in Idiopathic Nephrotic Syndrome 2010 ·The Journal of Pediatrics ·Marina Vivarelli, Eleonora Moscaritolo, Aggelos Tsalkidis, Laura Massella, Francesco Emma	44
13	Cobalamin C defect presenting as severe neonatal hyperammonemia 2010 ·European Journal of Pediatrics ·Diego Martinelli, Andrea Dotta, Laura Massella, Stefano Picca, (unknown), Sara Boenzi, Chiara Aiello, Carlo Dionisi‐Vici	10
14	Renal-coloboma syndrome: a single nucleotide deletion in the PAX2 gene at Exon 8 is associated with a highly variable phenotype 2007 ·Clinical Nephrology ·Anna Taranta, Alessandro Palma, Viviana De Luca, Antonino Romanzo, Laura Massella, Francesco Emma, Luca Dello Strologo	11
15	Epidermal basement membrane α5(IV) expression in females with Alport syndrome and severity of renal disease 2003 ·Kidney International ·Laura Massella, Andrea Onetti Muda, Tullio Faraggiana, (unknown), Alessandra Renieri, Gianfranco Rizzoni	20
16	Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin 2003 ·American Journal of Kidney Diseases ·Roberta Bertelli, Fabrizio Ginevri, Gianluca Caridi, Monica Dagnino, Silvio Sandrini, Marco Di Duca, Francesco Emma, Simone Sanna‐Cherchi, Francesco Scolari, Tauro Maria Neri, Luisa Murer, Laura Massella, Giancarlo Basile, Gianfranco Rizzoni, Francesco Perfumo, Gian Marco Ghiggeri	101
17	Distribution of α‐chains of type IV collagen in glomerular basement membranes with ultrastructural alterations suggestive of Alport syndrome 2001 ·Nephrology Dialysis Transplantation ·Paola Barsotti, Andrea Onetti Muda, Gianna Mazzucco, Laura Massella, Bruno Basolo, Mario Marchi, Gianfranco Rizzoni, Guido Monga, Tullio Faraggiana	13
18	Ultrastructural immunocytochemistry of collagenous and non-collagenous proteins in fast-frozen, freeze-substituted, and low-temperature-embedded renal tissue in Alport syndrome 1997 ·The Journal of Pathology ·Andrea Onetti Muda, Siavash Rahimi, Alessandra Renieri, Gianfranco Rizzoni, Laura Massella, Tullio Faraggiana	4
19	A novel missense mutation in exon 3 of the COL4A5 gene associated with late‐onset Alport syndrome 1995 ·Clinical Genetics ·Alberto Turco, Sandro Rossetti, Maria Olivia Biasi, Gianfranco Rizzoni, Laura Massella, (unknown), Alessandra Renieri, Pier Franco Pignatti, Mario Marchi	5
20	De novo mutation in the COL4A5 gene converting glycine 325 to glutamic acid in Alport syndrome 1992 ·Human Molecular Genetics ·Alessandra Renieri, Marco Seri, Jeanne C. Myers, Taina Pihlajaniemi, Laura Massella, Gianfranco Rizzoni, Mario Marchi	26

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact